Number of Metastatic Sites

Capomulin performed the best compared to Infubinol, Ketapril, and Placebo. After the treatment duration of 45 days, Capomulin had an average of 1.47 metastatic sites. Infubinol had an average of 2.11 sites, Ketapril had an average of 3.36 sites, and Placebo had an average of 3.27 sites. Thus, Capomulin is the most effective drug for average metastatic sites and Ketapril is the least effective.